Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H45IO |
| Molecular Weight | 516.5517 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C[131I])[C@H]3CC[C@]12C
InChI
InChIKey=FIOAEFCJGZJUPW-ODFYUTSGSA-N
InChI=1S/C27H45IO/c1-18(2)6-5-7-19(3)23-10-11-24-22-9-8-20-16-21(29)12-15-27(20,17-28)25(22)13-14-26(23,24)4/h8,18-19,21-25,29H,5-7,9-17H2,1-4H3/t19-,21+,22+,23-,24+,25+,26-,27-/m1/s1/i28+4
Iodocholesterol I-131 is a radioiodine-labeled cholesterol analog used as a diagnostic agent for Cushing's syndrome, hyperaldosteronism, and pheochromocytoma. Iodocholesterol I-131 accumulates in tissues where steroid hormones are produced, including the adrenal glands the ovaries and the testes. After binding to low-density lipoprotein (LDL) receptors on adrenocortical cells, Iodocholesterol I-131 is internalized. As cholesterol is the precursor for all adrenocortical steroid hormones, areas of hormonal hypersecretion can be visualized using scintigraphy and the adrenocortical function can be assessed.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
V09XA02
Created by
admin on Wed Apr 02 09:42:25 GMT 2025 , Edited by admin on Wed Apr 02 09:42:25 GMT 2025
|
||
|
WHO-VATC |
QV09XA02
Created by
admin on Wed Apr 02 09:42:25 GMT 2025 , Edited by admin on Wed Apr 02 09:42:25 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C133023
Created by
admin on Wed Apr 02 09:42:25 GMT 2025 , Edited by admin on Wed Apr 02 09:42:25 GMT 2025
|
PRIMARY | |||
|
450510
Created by
admin on Wed Apr 02 09:42:25 GMT 2025 , Edited by admin on Wed Apr 02 09:42:25 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110675
Created by
admin on Wed Apr 02 09:42:25 GMT 2025 , Edited by admin on Wed Apr 02 09:42:25 GMT 2025
|
PRIMARY | |||
|
SUB08215MIG
Created by
admin on Wed Apr 02 09:42:25 GMT 2025 , Edited by admin on Wed Apr 02 09:42:25 GMT 2025
|
PRIMARY | |||
|
100000083611
Created by
admin on Wed Apr 02 09:42:25 GMT 2025 , Edited by admin on Wed Apr 02 09:42:25 GMT 2025
|
PRIMARY | |||
|
DB13797
Created by
admin on Wed Apr 02 09:42:25 GMT 2025 , Edited by admin on Wed Apr 02 09:42:25 GMT 2025
|
PRIMARY | |||
|
4578
Created by
admin on Wed Apr 02 09:42:25 GMT 2025 , Edited by admin on Wed Apr 02 09:42:25 GMT 2025
|
PRIMARY | |||
|
4443
Created by
admin on Wed Apr 02 09:42:25 GMT 2025 , Edited by admin on Wed Apr 02 09:42:25 GMT 2025
|
PRIMARY | |||
|
C5F4248GPJ
Created by
admin on Wed Apr 02 09:42:25 GMT 2025 , Edited by admin on Wed Apr 02 09:42:25 GMT 2025
|
PRIMARY | |||
|
42220-21-3
Created by
admin on Wed Apr 02 09:42:25 GMT 2025 , Edited by admin on Wed Apr 02 09:42:25 GMT 2025
|
PRIMARY | |||
|
DTXSID60962377
Created by
admin on Wed Apr 02 09:42:25 GMT 2025 , Edited by admin on Wed Apr 02 09:42:25 GMT 2025
|
PRIMARY |
ACTIVE MOIETY